PAG
IHE icon

Pinnacle Advisory Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Pinnacle Advisory Group’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,919
Closed -$713K – 253
2020
Q4 		$713K Buy
11,919
+1,974
+20% +$113K 0.04% 112
2020
Q3 		$542K Hold
9,945
– – 0.04% 123
2020
Q2 		$510K Hold
9,945
– – 0.04% 122
2020
Q1 		$446K Hold
9,945
– – 0.04% 113
2019
Q4 		$531K Hold
9,945
– – 0.04% 116
2019
Q3 		$464K Hold
9,945
– – 0.03% 115
2019
Q2 		$500K Hold
9,945
– – 0.03% 115
2019
Q1 		$510K Hold
9,945
– – 0.04% 110
2018
Q4 		$467K Hold
9,945
– – 0.04% 110
2018
Q3 		$556K Sell
9,945
-351
-3% -$19.2K 0.04% 106
2018
Q2 		$519K Sell
10,296
-282
-3% -$14K 0.03% 102
2018
Q1 		$520K Sell
10,578
-525
-5% -$26.9K 0.03% 118
2017
Q4 		$571K Sell
11,103
-1,035
-9% -$53.2K 0.03% 124
2017
Q3 		$633K Sell
12,138
-401,538
-97% -$20.6M 0.04% 106
2017
Q2 		$21.4M Buy
413,676
+11,877
+3% +$600K 1.36% 27
2017
Q1 		$20.2M Sell
401,799
-2,322
-0.6% -$115K 1.32% 27
2016
Q4 		$19.1M Buy
404,121
+396,366
+5,111% +$18.8M 1.29% 29
2016
Q3 		$375K Sell
7,755
-150
-2% -$7.61K 0.03% 82
2016
Q2 		$380K Sell
7,905
-729
-8% -$34.7K 0.03% 86
2016
Q1 		$394K Sell
8,634
-1,665
-16% -$77.9K 0.04% 68
2015
Q4 		$555K Hold
10,299
– – 0.05% 57
2015
Q3 		$508K Sell
10,299
-5,115
-33% -$293K 0.05% 54
2015
Q2 		$898K Sell
15,414
-28,587
-65% -$1.67M 0.09% 39
2015
Q1 		$2.53M Sell
44,001
-90
-0.2% -$4.92K 0.23% 34
2014
Q4 		$2.23M Sell
44,091
-720
-2% -$35.1K 0.2% 38
2014
Q3 		$2.1M Sell
44,811
-3,282
-7% -$148K 0.27% 28
2014
Q2 		$2.17M Buy
+48,093
New +$2.07M 0.25% 28
2014
Q1 		– Sell
-50,490
Closed -$1.99M – 115
2013
Q4 		$1.99M Sell
50,490
-1,140
-2% -$42.8K 0.24% 25
2013
Q3 		$1.83M Sell
51,630
-1,320
-2% -$46.5K 0.21% 35
2013
Q2 		$1.76M Buy
+52,950
New +$1.76M 0.23% 27

Other funds holding IHE

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Pinnacle Advisory Group's IHE Position: Q1 2021 in Review

Pinnacle Advisory Group sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2021, closing a stake of 11,919 shares — an estimated $713K sold.

Pinnacle Advisory Group first reported a position in IHE in Q2 2013 and held it in 30 quarters. The position peaked at $21.4M in Q2 2017. 101 funds tracked by Wall St. Rank hold IHE as of Q1 2021.

  • Pinnacle Advisory Group reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2021 after selling out during the quarter.
  • Pinnacle Advisory Group sold 11,919 iShares US Pharmaceuticals ETF shares in Q1 2021, an estimated $713K.
  • Pinnacle Advisory Group first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 30 quarters.
  • Pinnacle Advisory Group's iShares US Pharmaceuticals ETF position peaked at $21.4M in Q2 2017.
  • 101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2021.

Based on Pinnacle Advisory Group's 13F filing for Q1 2021, filed 12 May 2021.